Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
The purpose of Case-Specific Health Care Professional (HCP) Clinical Survey of Liberant™ Thrombectomy System, also known as the Liberant Clinical Assessment, is to collect first-in-human clinical data to confirm the safety and performance of the Medtronic Liberant™ thrombectomy system when used for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems
Eligibility
Participation Requirements
Sex: All
Minimum Age: 22
Healthy Volunteers: f
View:
⁃ Patient case selection to be included in the clinical assessment will be specific to Liberant and will be made according to the following criteria:
• Patient treated is age ≥ 22 years at the time of procedure
• Use of Liberant in accordance with the device labeling within 72 hours of index procedure
Locations
United States
Washington, D.c.
MedStar Health
RECRUITING
Washington D.c.
Florida
Naples Comprehensive Health
RECRUITING
Naples
Contact Information
Primary
Manasa Gudipally
manasa.gudipally@medtronic.com
763-514-4000
Backup
Elizabeth Hunt
elizabeth.m.hunt@medtronic.com
Time Frame
Start Date: 2026-02-24
Estimated Completion Date: 2026-10
Participants
Target number of participants: 50
Related Therapeutic Areas
Sponsors
Leads: Medtronic Endovascular